ATTENTION NASDAQ: REGN INVESTORS: Contact Berger Montague About a Regeneron Pharmaceuticals, Inc. Class Action Lawsuit
PHILADELPHIA, Jan. 13, 2025 /PRNewswire/ -- A securities class action lawsuit has been filed against REGENERON PHARMACEUTICALS, INC. ("Regeneron" or the "Company") (NASDAQ: REGN). The lawsuit has been filed on